Trial Profile
Non-invasive parameters in the evaluation of portal hypertension in patients with liver cirrhosis and their significance for the evolution of cardial complications.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Portal hypertension
- Focus Therapeutic Use
- 25 Nov 2016 New trial record